Delivery Order SPE2DR25D1202-SPE2DR26F72CL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,122.42. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count packaging) with a ceiling value of $12,838.18. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 16, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a discrete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $2,125.32 and a firm fixed price structure. This delivery order is non-set-aside and competitively awarded, with an ultimate completion date of October 28, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules in quantities of 100 units, with a contract ceiling value of $1,133.20 and a firm fixed price structure. The award is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,090.52 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count) with a ceiling value of $1,274.82. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, carries no set-aside designation and represents a competitively awarded transaction. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,267.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100 count) at a ceiling value of $2,286.88. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $2,675.76. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72CLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) with a ceiling value of $2,155.26 and a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military healthcare systems worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal pharmaceutical needs across multiple therapeutic categories, including controlled substances such as this amphetamine formulation, which supports military medical operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/12/25 |